432 related articles for article (PubMed ID: 17882949)
21. Potent inhibition of human cardiac potassium (HERG) channels by the anti-estrogen agent clomiphene-without QT interval prolongation.
Yuill KH; Borg JJ; Ridley JM; Milnes JT; Witchel HJ; Paul AA; Kozlowski RZ; Hancox JC
Biochem Biophys Res Commun; 2004 May; 318(2):556-61. PubMed ID: 15120636
[TBL] [Abstract][Full Text] [Related]
22. The effects of sevoflurane and propofol on QT interval and heterologously expressed human ether-a-go-go related gene currents in Xenopus oocytes.
Yamada M; Hatakeyama N; Malykhina AP; Yamazaki M; Momose Y; Akbarali HI
Anesth Analg; 2006 Jan; 102(1):98-103. PubMed ID: 16368812
[TBL] [Abstract][Full Text] [Related]
23. Identification of IKr and its trafficking disruption induced by probucol in cultured neonatal rat cardiomyocytes.
Guo J; Massaeli H; Li W; Xu J; Luo T; Shaw J; Kirshenbaum LA; Zhang S
J Pharmacol Exp Ther; 2007 Jun; 321(3):911-20. PubMed ID: 17377062
[TBL] [Abstract][Full Text] [Related]
24. The hERG potassium channel as a therapeutic target.
Witchel HJ
Expert Opin Ther Targets; 2007 Mar; 11(3):321-36. PubMed ID: 17298291
[TBL] [Abstract][Full Text] [Related]
25. Long QT syndrome in neonates: conduction disorders associated with HERG mutations and sinus bradycardia with KCNQ1 mutations.
Lupoglazoff JM; Denjoy I; Villain E; Fressart V; Simon F; Bozio A; Berthet M; Benammar N; Hainque B; Guicheney P
J Am Coll Cardiol; 2004 Mar; 43(5):826-30. PubMed ID: 14998624
[TBL] [Abstract][Full Text] [Related]
26. A common antitussive drug, clobutinol, precipitates the long QT syndrome 2.
Bellocq C; Wilders R; Schott JJ; Louérat-Oriou B; Boisseau P; Le Marec H; Escande D; Baró I
Mol Pharmacol; 2004 Nov; 66(5):1093-102. PubMed ID: 15280442
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanisms for drug interactions with hERG that cause long QT syndrome.
Stansfeld PJ; Sutcliffe MJ; Mitcheson JS
Expert Opin Drug Metab Toxicol; 2006 Feb; 2(1):81-94. PubMed ID: 16863470
[TBL] [Abstract][Full Text] [Related]
28. [Current classification of anti-arrhythmia agents].
Weirich J; Wenzel W
Z Kardiol; 2000; 89 Suppl 3():62-7. PubMed ID: 10810787
[TBL] [Abstract][Full Text] [Related]
29. Determination of hERG channel blockers using a decision tree.
Gepp MM; Hutter MC
Bioorg Med Chem; 2006 Aug; 14(15):5325-32. PubMed ID: 16616507
[TBL] [Abstract][Full Text] [Related]
30. Block of hERG channel by ziprasidone: biophysical properties and molecular determinants.
Su Z; Chen J; Martin RL; McDermott JS; Cox BF; Gopalakrishnan M; Gintant GA
Biochem Pharmacol; 2006 Jan; 71(3):278-86. PubMed ID: 16325148
[TBL] [Abstract][Full Text] [Related]
31. Blockade of HERG K+ channel by an antihistamine drug brompheniramine requires the channel binding within the S6 residue Y652 and F656.
Park SJ; Kim KS; Kim EJ
J Appl Toxicol; 2008 Mar; 28(2):104-11. PubMed ID: 17516459
[TBL] [Abstract][Full Text] [Related]
32. Hydroxypropyl beta-cyclodextrins: a misleading vehicle for the in vitro hERG current assay.
Mikhail A; Fischer C; Patel A; Long MA; Limberis JT; Martin RL; Cox BF; Gintant GA; Su Z
J Cardiovasc Pharmacol; 2007 May; 49(5):269-74. PubMed ID: 17513944
[TBL] [Abstract][Full Text] [Related]
33. Quantitative structure-activity relationship studies on inhibition of HERG potassium channels.
Yoshida K; Niwa T
J Chem Inf Model; 2006; 46(3):1371-8. PubMed ID: 16711756
[TBL] [Abstract][Full Text] [Related]
34. The action of the novel gastrointestinal prokinetic prucalopride on the HERG K+ channel and the common T897 polymorph.
Chapman H; Pasternack M
Eur J Pharmacol; 2007 Jan; 554(2-3):98-105. PubMed ID: 17109852
[TBL] [Abstract][Full Text] [Related]
35. Distinct gene-specific mechanisms of arrhythmia revealed by cardiac gene transfer of two long QT disease genes, HERG and KCNE1.
Hoppe UC; Marbán E; Johns DC
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5335-40. PubMed ID: 11320260
[TBL] [Abstract][Full Text] [Related]
36. Expression of human ERG K+ channels in the mouse heart exerts anti-arrhythmic activity.
Royer A; Demolombe S; El Harchi A; Le Quang K; Piron J; Toumaniantz G; Mazurais D; Bellocq C; Lande G; Terrenoire C; Motoike HK; Chevallier JC; Loussouarn G; Clancy CE; Escande D; Charpentier F
Cardiovasc Res; 2005 Jan; 65(1):128-37. PubMed ID: 15621040
[TBL] [Abstract][Full Text] [Related]
37. Insights for human ether-a-go-go-related gene potassium channel inhibition using recursive partitioning and Kohonen and Sammon mapping techniques.
Ekins S; Balakin KV; Savchuk N; Ivanenkov Y
J Med Chem; 2006 Aug; 49(17):5059-71. PubMed ID: 16913696
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological activation of rapid delayed rectifier potassium current suppresses bradycardia-induced triggered activity in the isolated guinea pig heart.
Hansen RS; Olesen SP; Grunnet M
J Pharmacol Exp Ther; 2007 Jun; 321(3):996-1002. PubMed ID: 17325228
[TBL] [Abstract][Full Text] [Related]
39. Na+ permeation and block of hERG potassium channels.
Gang H; Zhang S
J Gen Physiol; 2006 Jul; 128(1):55-71. PubMed ID: 16769794
[TBL] [Abstract][Full Text] [Related]
40. Translational toxicology and rescue strategies of the hERG channel dysfunction: biochemical and molecular mechanistic aspects.
Zhang KP; Yang BF; Li BX
Acta Pharmacol Sin; 2014 Dec; 35(12):1473-84. PubMed ID: 25418379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
